These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 3394816
1. Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function. Nichols WW, Mehta JL, Thompson L, Donnelly WH. Am J Physiol; 1988 Jul; 255(1 Pt 2):H153-9. PubMed ID: 3394816 [Abstract] [Full Text] [Related]
2. Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4. Wargovich T, Mehta J, Nichols WW, Pepine CJ, Conti CR. J Am Coll Cardiol; 1985 Nov; 6(5):1047-51. PubMed ID: 4045029 [Abstract] [Full Text] [Related]
3. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists. Ashton JH, Schmitz JM, Campbell WB, Ogletree ML, Raheja S, Taylor AL, Fitzgerald C, Buja LM, Willerson JT. Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279 [Abstract] [Full Text] [Related]
4. Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction. Torii T, Toki Y, Hieda N, Ito Y, Okumura K, Hashimoto H, Ito T, Ogawa K, Satake T. Heart Vessels; 1988 Nov; 4(2):104-11. PubMed ID: 3253270 [Abstract] [Full Text] [Related]
5. Attenuation of coronary flow reserve and myocardial function after temporary subtotal coronary artery occlusion and increased myocardial oxygen demand in dogs. Nichols WW, Nicolini FA, Yang B, Robbins WC, Katopodis J, Chen L, Saldeen TG, Mehta JL. J Am Coll Cardiol; 1994 Sep; 24(3):795-803. PubMed ID: 8077555 [Abstract] [Full Text] [Related]
14. Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels. Wright L, Homans DC, Laxson DD, Dai XZ, Bache RJ. J Am Coll Cardiol; 1992 Mar 01; 19(3):687-93. PubMed ID: 1538028 [Abstract] [Full Text] [Related]
15. Thromboxane is produced in response to intracoronary infusions of complement C5a in pigs. Cyclooxygenase blockade does not reduce the myocardial ischemia and leukocyte accumulation. Ito BR, Roth DM, Chenoweth DE, Lefer AM, Engler RL. Circ Res; 1989 Nov 01; 65(5):1220-32. PubMed ID: 2509096 [Abstract] [Full Text] [Related]
16. Neuropeptide Y and coronary vasoconstriction: role of thromboxane A2. Martin SE, Kuvin JT, Offenbacher S, Odle BM, Patterson RE. Am J Physiol; 1992 Oct 01; 263(4 Pt 2):H1045-53. PubMed ID: 1415751 [Abstract] [Full Text] [Related]
17. Inhibition of leukotriene D4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dog. Kopia GA, Valocik RE, Torphy TJ, Cieslinksi LB, Sarau HM, Foley JJ, Wasserman MA. J Pharmacol Exp Ther; 1987 Apr 01; 241(1):174-80. PubMed ID: 2437287 [Abstract] [Full Text] [Related]
18. Effects of leukotriene D4 on large and small coronary arteries in the conscious dog. Hintze TH, Stern H, Kaley G. Adv Prostaglandin Thromboxane Leukot Res; 1986 Apr 01; 16():287-98. PubMed ID: 2949554 [No Abstract] [Full Text] [Related]
19. Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Sellke FW, Wang SY, Friedman M, Harada K, Edelman ER, Grossman W, Simons M. Am J Physiol; 1994 Oct 01; 267(4 Pt 2):H1303-11. PubMed ID: 7943375 [Abstract] [Full Text] [Related]
20. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo. Kamijo T, Iwai T, Haruta K, Takeda K. Arch Int Pharmacodyn Ther; 1996 Oct 01; 331(3):273-84. PubMed ID: 9124999 [Abstract] [Full Text] [Related] Page: [Next] [New Search]